Literature DB >> 6168929

Successful immunization against experimental allergic encephalomyelitis with myelin basic protein-sensitized allogeneic lymphocytes.

G A Hashim.   

Abstract

Prevention and suppression of experimental allergic encephalomyelitis were demonstrated in rats, guinea pigs, and rabbits immunized with allogeneic, but not with syngeneic lymphocytes from susceptible donors sensitized to myelin basic protein (MBP). Donor lymphnode, splenic, or peripheral blood lymphocytes were effective in inducing a state of unresponsiveness to an encephalitogenic challenge in either of the three species. Unresponsiveness was not obtained in recipients immunized with sensitized allogenic lymphocytes and simultaneously challenged with MBP suggesting that a time lapse between immunization and challenge is necessary for the development of protective immunity. Induced in immunized recipients, unresponsiveness was transferred into normal syngeneic recipients with immunoglobulin-G (IgG) isolated from protected donors before challenge. Furthermore, both immunized and IgG recipients failed to develop cell-mediated immunity after challenge with MBP. The results show that prevention and suppression of EAE was mediated by antibodies which inhibited the development of delayed type hypersensitivity to the challenging antigen.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168929     DOI: 10.1007/BF00963886

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

1.  Genetic control of susceptibility to experimental allergic encephalomyelitis and the Ag-B locus of rats.

Authors:  D L Gasser; J Palm; N K Gonatas
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

2.  FURTHER IMMUNOLOGIC STUDIES OF ADJUVANT DISEASE IN THE RAT.

Authors:  M FLAX; B H WAKSMAN
Journal:  Int Arch Allergy Appl Immunol       Date:  1963

3.  Delayed cutaneous reactions in the rat.

Authors:  M H FLAX; B H WAKSMAN
Journal:  J Immunol       Date:  1962-10       Impact factor: 5.422

4.  [Prevention of allergic encephalomyelitis by prior injection of adjuvants].

Authors:  M W KIES; E C ALVORD
Journal:  Nature       Date:  1958-10-18       Impact factor: 49.962

5.  The antibody response to myelin basic protein (BP) in Lewis rats: the effect of time, dosage of BP, and dosage of Mycobacterium butyricum.

Authors:  E D Day; O M Pitts
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

6.  Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats.

Authors:  S Levine; R Sowinski
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

7.  Experimental allergic encephalomyelitis in Lewis rats: immunoregulation of disease by a single amino acid substitution in the disease-inducing determinant.

Authors:  E Kardys; G A Hashim
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

8.  The development of experimental allergic encephalomyelitis with immunizing doses of myelin basic protein.

Authors:  G A Hashim; R D Sharpe; E Carvalho; L E Stevens
Journal:  Proc Soc Exp Biol Med       Date:  1975-07

9.  Experimental allergic encephalomyelitis: structural specificity of determinants for delayed hypersensitivity.

Authors:  G A Hashim; R D Sharpe
Journal:  Immunochemistry       Date:  1974-10

10.  Suppression of allergic encephalomyelitis in rats by means of antibrain serum.

Authors:  P Y PATERSON; S M HARWIN
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

View more
  1 in total

1.  Experimental allergic encephalomyelitis in guinea pig: variability of response to intradermal emulsion injection.

Authors:  D Gambi; N Di Cesare; G Di Trapani; G Macchi; A Sbriccoli
Journal:  Ital J Neurol Sci       Date:  1989-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.